Search

everythinglearnresearchcommunity

for

Search:↓

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Breast cancer hormone therapy can cause hair loss, which can be treated with daily applications of specific topical solutions like minoxidil and hydrocortisone butyrate.

Skin lesions in Carney complex are likely caused by a specific group of skin cells that promote pigment production due to a genetic mutation.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Hair follicles are complex, dynamic mini-organs that help us understand cell growth, death, migration, and differentiation, as well as tissue regeneration and tumor biology.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Epithelial-mesenchymal interactions control hair growth cycles through specific molecular signals.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

A woman's excessive hair growth was caused by a rare benign tumor in her adrenal gland, which was successfully removed.

A young woman's rare ovarian tumor was successfully removed, improving her hormonal symptoms.

Maxillariinae orchids contain 62 compounds with potential health benefits, including treating skin conditions and diseases like cancer and diabetes.

A 17-year-old girl was diagnosed with a rare ovarian tumor, emphasizing the need for fertility preservation and psychosocial care.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Using steroids can increase the risk of heart problems.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.